BDBM463322 (+-)-2-Methyl-3-((3-methoxy- 4,6-difluoro)benzylamino)-N- (9-chloro-3,4-dihydro-2H-1,5- benzodioxepin-7-ylmethyl)-N- isobutylpropanamide::US10780095, Structure TABLE 1.20

SMILES COc1cc(CNCC(C)C(=O)N(CC(C)C)Cc2cc(Cl)c3OCCCOc3c2)c(F)cc1F

InChI Key InChIKey=LCDTUEYJODXDPZ-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 463322   

TargetProkineticin receptor 1(Human)
University of California

US Patent
LigandPNGBDBM463322((+-)-2-Methyl-3-((3-methoxy- 4,6-difluoro)benzylam...)
Affinity DataKi:  43.5nMAssay Description:An aequorin-based luminescent assay for calcium mobilization was used to measure mobilization of intracellular Ca2+ (Bullock et al., Mol Pharmacol 65...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2021
Entry Details
Go to US Patent